Fondaparinux in the initial and long-term treatment of venous thromboembolism

Keyphrases

• Long-term Treatment 100%
• Venous Thromboembolism 100%
• Fondaparinux 100%
• Major Bleeding 30%
• Heparin 20%
• Low Molecular Weight Heparin 20%
• Initial Treatment 10%
• Cancer Patients 10%
• In Cancer 10%
• Everyday Practices 10%
• Vitamin K Antagonists 10%
• Enfermedad 10%
• Recurrent Venous Thromboembolism 10%
• Patients with Cancer 10%
• Long-term Efficacy 10%
• Long-term Safety 10%
• Propensity Score Matching 10%
• Absence of Evidence 10%
• Non-cancer 10%
• Number of Patients 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Venous Thromboembolism 100%
• Fondaparinux 100%
• Malignant Neoplasm 80%
• Bleeding 30%
• Low Molecular Weight Heparin 20%
• Heparin 20%
• Recurrent Disease 10%
• Absence 10%
• Antivitamin K 10%